FSD BIO LABS · Product artwork
Studied for collagen production, skin biology and tissue-remodelling processes.
19 vials available
Full prepaid by UPI includes free delivery. COD requires 5% advance and a 1.5% delivery fee. Payment details
See delivery information and return conditions before ordering. Your final total is shown at checkout.
COA not yet available for this strength
Not for human or veterinary administration. Listed strength is a supplied specification; see the matching batch report for measured results.
GHK-Cu is the copper complex of the tripeptide glycyl-histidyl-lysine. Laboratory research examines how it influences fibroblasts, the cells that help produce the structural matrix of skin and other tissues.
Each source identifies what was studied and the limits of its findings. Published research is separate from this product’s batch COA.
Foundational fibroblast experiments examined collagen synthesis in response to the copper-peptide complex. Laboratory collagen responses do not establish cosmetic or wound-healing outcomes in people.
Read sourceHuman fibroblast cultures and skin samples were used to study collagen responses to GHK-Cu combined with hyaluronic acid. The findings concern that experimental combination, not GHK-Cu alone or an injected product.
Read sourceGHK-Cu is currently listed in 50 mg, 100 mg. Select a strength above to see its price, product image and current stock. Listed quantities are supplied specifications, not measured batch results.
3 laboratory reports are published for this compound. Match the selected strength and available batch identifiers, and open the original document to check the actual test scope.
The references discuss the material and experimental conditions in those studies. They do not verify the identity, purity, quantity or suitability of this catalogue vial. Review the study limitations and the available batch documentation separately.
A 70 mg research blend of GHK-Cu (50 mg), BPC-157 (10 mg) and TB-500 (10 mg), bringing together components studied in connective-tissue and cellular-response research.
An 80 mg research blend of GHK-Cu (50 mg), BPC-157 (10 mg), TB-500 (10 mg) and KPV (10 mg), combining components studied in tissue biology and inflammatory signalling.